Nxera Pharma Co., Ltd. (TYO: 4565)

Nxera Pharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48,868	49,065	66,557	60,087	40,008	15,375
Cash & Short-Term Investments	48,868	49,065	66,557	60,087	40,008	15,375
Cash Growth	15.29%	-26.28%	10.77%	50.19%	160.21%	-18.04%
Accounts Receivable	4,964	5,064	2,462	2,138	939	1,924
Other Receivables	1,963	6,823	140	103	732	1,765
Receivables	6,927	11,887	2,602	2,241	1,671	3,689
Inventory	1,631	2,903	-	-	-	-
Prepaid Expenses	-	790	638	388	322	-
Other Current Assets	2,435	467	145	92	17	499
Total Current Assets	59,861	65,112	69,942	62,808	42,018	19,563
Property, Plant & Equipment	7,582	7,900	3,791	3,817	3,824	4,120
Long-Term Investments	4,156	3,308	1,801	6,145	4,687	5,633
Goodwill	25,274	24,623	15,306	-	-	-
Other Intangible Assets	51,540	52,291	8,577	24,215	25,936	27,364
Long-Term Deferred Tax Assets	3,895	3,964	-	-	-	-
Other Long-Term Assets	30	-	-	-	-	-
Total Assets	152,338	157,198	99,417	96,985	76,465	56,680
Accounts Payable	3,467	4,244	1,628	1,176	1,508	1,211
Accrued Expenses	-	-	400	570	167	-
Current Portion of Long-Term Debt	5,798	5,941	-	-	-	-
Current Portion of Leases	858	832	176	193	170	175
Current Income Taxes Payable	197	4,640	260	279	29	162
Current Unearned Revenue	-	1,388	1,450	785	784	-
Other Current Liabilities	4,626	140	178	4,188	327	755
Total Current Liabilities	14,946	17,185	4,092	7,191	2,985	2,303
Long-Term Debt	59,099	63,215	27,981	27,440	14,789	-
Long-Term Leases	3,654	3,985	1,577	1,638	1,664	1,704
Long-Term Deferred Tax Liabilities	2,324	1,490	2,922	2,706	2,457	2,008
Other Long-Term Liabilities	4,555	4,513	4,909	542	2,189	5,587
Total Liabilities	84,578	90,388	41,481	39,517	24,084	11,602
Common Stock	47,172	46,807	41,335	41,036	40,220	37,479
Additional Paid-In Capital	34,707	34,048	29,525	29,100	30,452	26,548
Retained Earnings	-19,607	-16,104	-8,911	-9,768	-10,785	-12,264
Treasury Stock	-3	-1	-1	-	-	-
Comprehensive Income & Other	5,491	2,060	-4,012	-2,900	-7,506	-6,688
Total Common Equity	67,760	66,810	57,936	57,468	52,381	45,075
Minority Interest	-	-	-	-	-	3
Shareholders' Equity	67,760	66,810	57,936	57,468	52,381	45,078
Total Liabilities & Equity	152,338	157,198	99,417	96,985	76,465	56,680
Total Debt	69,409	73,973	29,734	29,271	16,623	1,879
Net Cash (Debt)	-20,541	-24,908	36,823	30,816	23,385	13,496
Net Cash Growth	-	-	19.49%	31.78%	73.27%	14.41%
Net Cash Per Share	-232.95	-301.85	445.85	375.78	294.18	174.18
Filing Date Shares Outstanding	89.9	89.45	81.92	81.52	80.74	77.11
Total Common Shares Outstanding	89.9	89.45	81.92	81.52	80.6	77.07
Working Capital	44,915	47,927	65,850	55,617	39,033	17,260
Book Value Per Share	753.72	746.93	707.20	704.97	649.92	584.84
Tangible Book Value	-9,054	-10,104	34,053	33,253	26,445	17,711
Tangible Book Value Per Share	-100.71	-112.96	415.67	407.92	328.12	229.80

Source: S&P Capital IQ. Standard template. Financial Sources.